{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:55:48Z","timestamp":1776419748804,"version":"3.51.2"},"reference-count":48,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,3,4]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Nontuberculous mycobacterial pulmonary disease (NTM-PD) prevalence in Japan is among the highest worldwide. COPD and bronchiectasis are common comorbidities among patients with NTM-PD, and it is challenging to treat NTM-PD in patients with these conditions. There are limited data on the incremental burden that NTM-PD adds to underlying COPD or bronchiectasis in Japan. Therefore, the objective of this study was to assess the incremental burden associated with NTM-PD in patients with pre-existing COPD and\/or bronchiectasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This nested case\u2013control study was based on JMDC, Inc. claims data (2015\u20132020). Patients with COPD and\/or bronchiectasis with NTM-PD (cases) were age and sex matched 1:3 to patients with COPD and\/or bronchiectasis without NTM-PD (controls), resulting in three mutually exclusive patient groups (COPD, bronchiectasis or both; with or without NTM-PD). Incremental burden of NTM-PD was assessed within each group by comparing hospitalisations during the 1-year period after NTM-PD diagnosis (index) between cases and controls with both univariate analysis and multivariate analysis adjusting for pre-index comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariate analyses in the three patient groups consistently demonstrated incremental hospitalisation burden in cases<jats:italic>versus<\/jats:italic>controls (<jats:italic>e.g.<\/jats:italic>COPD group: 20% of 492 cases<jats:italic>versus<\/jats:italic>13% of 1476 controls had all-cause hospitalisations; 11%<jats:italic>versus<\/jats:italic>5% had respiratory-related hospitalisations; and 6%<jats:italic>versus<\/jats:italic>2% had COPD-related hospitalisations). Subsequent multivariate analysis further confirmed the findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The substantial incremental burden of hospitalisation associated with NTM-PD in patients with COPD and\/or bronchiectasis highlights the urgent need for appropriate management of NTM-PD in Japan.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00911-2023","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T16:35:18Z","timestamp":1710434118000},"page":"00911-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan"],"prefix":"10.1183","volume":"10","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-9275","authenticated-orcid":false,"given":"Kozo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjan","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2024101712212536000_10.4.00911-2023.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2024101712212536000_10.4.00911-2023.2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201303-067OC"},{"key":"2024101712212536000_10.4.00911-2023.3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ofid\/ofaa439.1674","article-title":"The incremental burden of nontuberculous mycobacterial lung disease (NTMLD) among patients with chronic obstructive pulmonary disease (COPD): hospitalizations and ER visits among US Medicare beneficiaries","volume":"7","author":"Wang","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.10.002"},{"key":"2024101712212536000_10.4.00911-2023.5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2024101712212536000_10.4.00911-2023.6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2206.151642"},{"key":"2024101712212536000_10.4.00911-2023.7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12890-019-0901-z","article-title":"Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study","volume":"19","author":"Park","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024101712212536000_10.4.00911-2023.8","first-page":"341","article-title":"Epidemiology of adults and children treated for nontuberculous mycobacterial pulmonary disease in Japan","volume":"16","author":"Izumi","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024101712212536000_10.4.00911-2023.9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.10","doi-asserted-by":"crossref","first-page":"e0128304","DOI":"10.1371\/journal.pone.0128304","article-title":"Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan","volume":"10","author":"Ide","year":"2015","journal-title":"PLoS One"},{"key":"2024101712212536000_10.4.00911-2023.11","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0148"},{"key":"2024101712212536000_10.4.00911-2023.12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.rmed.2018.10.022","article-title":"Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population","volume":"145","author":"Marras","year":"2018","journal-title":"Respir Med"},{"key":"2024101712212536000_10.4.00911-2023.13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12890-020-01304-6","article-title":"Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis","volume":"20","author":"Uno","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024101712212536000_10.4.00911-2023.14","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0638-0"},{"key":"2024101712212536000_10.4.00911-2023.15","first-page":"167","article-title":"CT features of pulmonary nontuberculous mycobacterial infection: effects of underlying pulmonary disease","volume":"18","author":"Takada","year":"2000","journal-title":"Radiat Med"},{"key":"2024101712212536000_10.4.00911-2023.16","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2016.79.2.74"},{"key":"2024101712212536000_10.4.00911-2023.17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/jiaa354","article-title":"Mycobacterium avium complex: addressing gaps in diagnosis and management","volume":"222","author":"Daley","year":"2020","journal-title":"J Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200805-686OC"},{"key":"2024101712212536000_10.4.00911-2023.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036902"},{"key":"2024101712212536000_10.4.00911-2023.20","first-page":"A3940","article-title":"Identifying potentially undiagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease: development of a predictive algorithm using claims data","volume":"203","author":"Wang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712212536000_10.4.00911-2023.21","first-page":"977","article-title":"Pulmonary disease by non-tuberculous mycobacteria \u2013 clinical management, unmet needs and future perspectives","volume":"11","author":"Larsson","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"2024101712212536000_10.4.00911-2023.22","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.jval.2021.04.1221","article-title":"How does mortality differ in early vs. late diagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease (COPD)","volume":"24","author":"Wang","year":"2021","journal-title":"Value in Health"},{"key":"2024101712212536000_10.4.00911-2023.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00535-2020"},{"key":"2024101712212536000_10.4.00911-2023.24","first-page":"33","article-title":"The incremental burden of nontuberculous mycobacterial lung disease (NTMLD) among patients with bronchiectasis (BE): hospitalizations and ER visits among US Medicare beneficiaries","volume":"6","author":"Wang","year":"2020","journal-title":"Eur Respir Pulmon Dis"},{"key":"2024101712212536000_10.4.00911-2023.25","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.422"},{"key":"2024101712212536000_10.4.00911-2023.26","unstructured":"Ministry of Education Culture, Sports, Science and Technology , Ministry of Health, Labour and Welfare , Ministry of Economy, Trade and Industry . [Ethical guidelines for medical and biological research involving human subjects]. https:\/\/www.mhlw.go.jp\/content\/000757566.pdf. Date last updated: 2022. Date last accessed: 4 January 2022."},{"key":"2024101712212536000_10.4.00911-2023.27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3201\/eid2703.203124","article-title":"Validity of diagnosis code-based claims to identify pulmonary NTM disease in bronchiectasis patients","volume":"27","author":"Ku","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.28","doi-asserted-by":"crossref","first-page":"1479973119839961","DOI":"10.1177\/1479973119839961","article-title":"Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice","volume":"16","author":"Seifer","year":"2019","journal-title":"Chron Respir Dis"},{"key":"2024101712212536000_10.4.00911-2023.29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02109-2016"},{"key":"2024101712212536000_10.4.00911-2023.30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"2024101712212536000_10.4.00911-2023.31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12879-023-08689-9","article-title":"Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.32","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/COPD.S133859","article-title":"Prevalence and characteristics of asthma\u2013COPD overlap syndrome identified by a stepwise approach","volume":"12","author":"Inoue","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101712212536000_10.4.00911-2023.33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.chest.2022.08.2228","article-title":"Gastroesophageal reflux disease increases susceptibility to nontuberculous mycobacterial pulmonary disease","volume":"163","author":"Kim","year":"2023","journal-title":"Chest"},{"key":"2024101712212536000_10.4.00911-2023.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2280"},{"key":"2024101712212536000_10.4.00911-2023.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1906"},{"key":"2024101712212536000_10.4.00911-2023.36","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310004506"},{"key":"2024101712212536000_10.4.00911-2023.37","doi-asserted-by":"crossref","first-page":"ofab035","DOI":"10.1093\/ofid\/ofab035","article-title":"Diagnostic accuracy of health care administrative diagnosis codes to identify nontuberculous mycobacteria disease: a systematic review","volume":"8","author":"Mejia-Chew","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024101712212536000_10.4.00911-2023.38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s13300-018-0407-3","article-title":"Characteristics, treatment patterns, and economic outcomes of patients initiating injectable medications for management of type 2 diabetes mellitus in Japan: results from a retrospective claims Database Analysis","volume":"9","author":"Suzuki","year":"2018","journal-title":"Diabetes Ther"},{"key":"2024101712212536000_10.4.00911-2023.39","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00051110"},{"key":"2024101712212536000_10.4.00911-2023.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.03.012"},{"key":"2024101712212536000_10.4.00911-2023.41","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.21037\/jtd-20-2263","article-title":"Narrative review of current COPD status in Japan","volume":"13","author":"Tanabe","year":"2021","journal-title":"J Thorac Dis"},{"key":"2024101712212536000_10.4.00911-2023.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023673"},{"key":"2024101712212536000_10.4.00911-2023.43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/COPD.S59962","article-title":"Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan","volume":"9","author":"Onishi","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101712212536000_10.4.00911-2023.44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1742-1241.2008.01873.x","article-title":"Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1\/FVC","volume":"63","author":"Fukahori","year":"2009","journal-title":"Int J Clin Pract"},{"key":"2024101712212536000_10.4.00911-2023.45","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00325-2019"},{"key":"2024101712212536000_10.4.00911-2023.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.09.011"},{"key":"2024101712212536000_10.4.00911-2023.47","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2021 report. Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Date last accessed 25 October 2021"},{"key":"2024101712212536000_10.4.00911-2023.48","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2023.PA2166"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00911-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:34:49Z","timestamp":1740375289000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00911-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,8]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1183\/23120541.00911-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00911-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}